Cargando…
Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers via dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer
Selective induction of breast cancer apoptosis is viewed as the mainstay of various ongoing oncology drug discovery programs. Passerini scaffolds have been recently exploited as selective apoptosis inducers via a caspase 3/7 dependent pathway. Herein, the optimized Passerini caspase activators were...
Autores principales: | Ayoup, Mohammed Salah, Wahby, Yasmin, Abdel-Hamid, Hamida, Abu-Serie, Marwa M., Ramadan, Sherif, Barakat, Assem, Teleb, Mohamed, Ismail, Magda M. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509784/ https://www.ncbi.nlm.nih.gov/pubmed/37736568 http://dx.doi.org/10.1039/d3ra04029a |
Ejemplares similares
-
Structure optimization of new tumor-selective Passerini α-acyloxy carboxamides as Caspase-3/7 activators
por: Ayoup, Mohammed Salah, et al.
Publicado: (2022) -
Keto-Enol Tautomerism in Passerini and Ugi Adducts
por: Pertejo, Pablo, et al.
Publicado: (2021) -
Two decades of recent advances of Ugi reactions: synthetic and pharmaceutical applications
por: Fouad, Manar Ahmed, et al.
Publicado: (2020) -
Innovations and
Inventions: Why Was the Ugi Reaction
Discovered Only 37 Years after the Passerini Reaction?
por: Dömling, Alexander
Publicado: (2022) -
Strain and Complexity, Passerini and Ugi Reactions of Four‐Membered Heterocycles and Further Elaboration of TOSMIC Product
por: Sztanó, Gábor, et al.
Publicado: (2023)